Hahaha Golf. Rest assured that when ever I have a few bucks they go into buying RVX shares. If I win the lottery much more will flow into RVX shares. Haha, perhaps then I'd talk to Don and get one of his discounted share+warrant packages. The price is far too low even without the Covid trial. Remember that along with many of it's numerous positive benefits apabetalone has been proven to increase functional HDL (specifically Apoa-l). I've flagged apabetalone to my kidney specialist. I need this stuff because I have PAD. If the Covid trial succeeds I hope my Dr will use it off label on me.

Also, I'm not a scientist, but I read in a science paper (can't remember but possibly Harvard Medical School?? or Cleveland Clinic) that increasing HDL is more important than lowering LDL because HDL is involved in reverse cholesterol transport (RCT). Remember, as I recall, we failed the RCT trial because management decided not to do the futility analysis. We also failed BoM because management decided not to do the futility analysis and the trial was statistically under powered. Scientists please slap my hands if I've stepped out of line here.

I've stated my opinion of management quite clearly numerous times. Like others have posted before, it is now time for the BOD to step up and do their job. They need to bring in a competent CEO quickly. There are only 2 directors, Shawn Lu (Hepa) and Dicky To (ORI Capital) that I would guess might have an interest in bringing in a competent CEO. It is time for these directors to start having independent discussions with the 3 other directors independent of Don in order to plan for succession. Don can become Chairman emeritus. The new CEO should report directly to the BOD which should have a new chairperson. This science is far too important to have it sit in limbo as it has for the past 2 years (since the results on BoM).

As I posted on Zenith Don seems to have gone through a manic phase starting in Sept 2020 and ending in the spring of 2021 and now he is in an "excuses" phase. Keep in mind that 2019 and 2020 were years in which we watched a number of Canadian biotechs reward their shareholders very handsomely. Don's like a deer caught in the head lights of an oncoming vehicle. He does not know which way to turn. 

I reserve the right to change my opinion 180 degrees and I will if I see some sort of strategic competence and evidence RVX is moving forward.

However, the most important issue to me is to get the Covid trial started and to see the dramatic results Don stated. Then wonderful things will happen.

Golf, as for my credibility I don't put much stock in it myself  :) and even less on relevance. The only reason I post is to organize my thoughts as best I can in order to make sense of this crazy situation.

 GLTA and happy long weekend.

Toinv